| scholarly article | Q13442814 |
| P2093 | author name string | David M Wood | |
| Paul I Dargan | |||
| Andrew Cunningham | |||
| Roumen Sedefov | |||
| P2860 | cites work | 2013 Annual Meeting of the North American Congress of Clinical Toxicology (NACCT) | Q28950849 |
| 2012 Annual Meeting of the North American Congress of Clinical Toxicology (NACCT) | Q28950874 | ||
| High-performance liquid chromatography tandem mass spectrometry method for the determination of 2CC-NBOMe and 25I-NBOMe in human serum | Q33829385 | ||
| A case of 25I-NBOMe (25-I) intoxication: a new potent 5-HT2A agonist designer drug | Q34331924 | ||
| Severe clinical toxicity associated with analytically confirmed recreational use of 25I-NBOMe: case series | Q34348317 | ||
| The NBOMe hallucinogenic drug series: Patterns of use, characteristics of users and self-reported effects in a large international sample | Q34406732 | ||
| Near fatal intoxication with the novel psychoactive substance 25C-NBOMe | Q34417353 | ||
| Limited use of novel psychoactive substances in South London nightclubs. | Q34639475 | ||
| 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing. | Q37633498 | ||
| Postmortem detection of 25I-NBOMe [2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine] in fluids and tissues determined by high performance liquid chromatography with tandem mass spectrometry from a traumatic death | Q37672302 | ||
| Determination of 4-bromo-2,5-dimethoxy-N-[(2-methoxyphenyl)methyl]-benzeneethanamine (25B-NBOMe) in serum and urine by high performance liquid chromatography with tandem mass spectrometry in a case of severe intoxication | Q37728569 | ||
| NBOMe - a very different kettle of fish . . . | Q44565420 | ||
| The electric Kool-Aid NBOMe test: LC-TOF/MS confirmed 2C-C-NBOMe (25C) intoxication at Burning Man. | Q45960232 | ||
| Pediatric ergot alkaloid exposures reported to the California Poison Control System: 1997-2008. | Q46102270 | ||
| Pathological findings in 2 cases of fatal 25I-NBOMe toxicity. | Q51166112 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 85-92 | |
| P577 | publication date | 2015-02-01 | |
| P1433 | published in | Clinical Toxicology | Q1101545 |
| P1476 | title | Prevalence of use and acute toxicity associated with the use of NBOMe drugs | |
| P478 | volume | 53 |
| Q48069477 | Case series: toxicity from 25B-NBOMe--a cluster of N-bomb cases |
| Q53063534 | Characterization of the hepatic cytochrome P450 enzymes involved in the metabolism of 25I-NBOMe and 25I-NBOH. |
| Q98193075 | Development and validation of a colour spot test method for the presumptive detection of 25-NBOMe compounds |
| Q41759552 | Healthcare professionals are less confident in managing acute toxicity related to the use of new psychoactive substances (NPS) compared with classical recreational drugs |
| Q50627353 | Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents. |
| Q30969880 | NBOMe and 2C substitute phenylethylamine exposures reported to the National Poison Data System |
| Q90344547 | NBOMes-Highly Potent and Toxic Alternatives of LSD |
| Q28276182 | NPS: Medical Consequences Associated with Their Intake |
| Q51482161 | Neurochemical binding profiles of novel indole and benzofuran MDMA analogues. |
| Q91811794 | Neurochemical pharmacology of psychoactive substituted N-benzylphenethylamines: High potency agonists at 5-HT2A receptors |
| Q26752739 | Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants |
| Q38963846 | New psychoactive substances: an overview on recent publications on their toxicodynamics and toxicokinetics |
| Q30251771 | Novel psychoactive substances: the pharmacology of stimulants and hallucinogens. |
| Q39093171 | Pharmacology and Toxicology of N-Benzylphenethylamine ("NBOMe") Hallucinogens |
| Q42379355 | Recommendations for specimen collection for NBOMe analysis in clinical toxicology |
| Q94949806 | Synthesis, determination of analytical characteristics and differentiation of positional isomers in the series of N-(2-methoxybenzyl)-2-(dimethoxyphenyl)ethanamine by means of chromatography-mass spectrometry |
| Q62630887 | What products are considered psychoactive under New Zealand's legal market for new psychoactive substances (NPS, ‘legal highs’)? Implications for law enforcement and penalties |
Search more.